Healthcare Equipment and Supplies
Company Overview of Nextremity Solutions, Inc.
Nextremity Solutions, Inc., a medical device company, engages in the research and development of extremely precise implants for extremity surgery. It offers MSP Metatarsal Shortening System, which provides precision and stability for metatarsal shortening procedures; Re+Line Bunion Correction System, a low profile tension-band compression plate for performing precise and repeatable bunion correction surgery; Nextra Hammertoe Correction System, an adjustable two-piece hammertoe implant; Precision Ready Systems, which include cortical compression staple system, internal drive mini-screw system, and opposing force compression screw system; and reimbursement support services. The company was inc...
210 North Buffalo Street
Warsaw, IN 46580
Founded in 2007
Key Executives for Nextremity Solutions, Inc.
Chief Financial Officer and Chief Operating Officer
Vice President and General Manager
Compensation as of Fiscal Year 2016.
Nextremity Solutions, Inc. Key Developments
Zimmer Biomet Expands Foot and Ankle Portfolio Through Exclusive Global Distribution Agreement with Nextremity Solutions, Inc
Oct 20 16
Zimmer Biomet Holdings, Inc. announced an exclusive agreement with Nextremity Solutions, Inc. to globally distribute the company's foot and ankle deformity correction products. The financial terms of the transaction were not disclosed.
Nextremity Solutions, Inc. Presents at 2015 Musculoskeletal New Ventures Conference, Nov-04-2015 09:30 AM
Nov 1 15
Nextremity Solutions, Inc. Presents at 2015 Musculoskeletal New Ventures Conference, Nov-04-2015 09:30 AM. Venue: The FedEx Institute of Technology at the University of Memphis, Memphis, Tennessee, United States. Speakers: Nick A. Deeter, Chairman and Chief Executive Officer.
Nextremity Solutions Announces Results of Study on the Efficacy of its Hammertoe Correction System
Jul 31 15
Nextremity Solutions announced the results of a study on the efficacy of its Hammertoe Correction System. The prospective randomized multicenter study demonstrated a 5.8x higher rate of bone fusion with Nextra's device compared to traditional K-Wires, as well as a 2.3x higher rate of Quality of Life over K-Wires.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries